Using CBD as a Natural Remedy for Anxiety

Using CBD as a Natural Remedy for Anxiety

For people suffering from anxiety, life can be an uphill battle. It can affect work and personal relationships for some, and prevent others from enjoying aspects of life which many take for granted. As a result, those who suffer from anxiety want to find ways to limit the suffocating effects it can have.

Cannabidiol (CBD) is a herbal alternative to treating anxiety which is steadily becoming widely recognized and used. This article takes a deep look into the clinical and scientific analysis of CBD to highlight why it’s a fantastic natural anxiety medicine.

What Is Anxiety?

Anxiety itself is a normal reaction deeply rooted in our primal survival insects of fight, flight or freeze. However, as we've evolved, the scenarios that trigger anxiety (like an imminent attack of a wild animal or having to find shelter against the elements) are no longer the same ones which we typically are now faced with.

Modern-day anxiety is often rooted in the fear of what might happen, rather than what is actually happening.

We may begin to feel anxious before we go into unknown circumstances such as a new social situation, an important meeting, or the doctor's office. This is because the brain starts to conjure up all of the possible negative outcomes which then begin to bubble underneath as anxiety. From there, anxiety can begin to manifest as excessive sweating, a dry mouth, tense muscles, and in worse cases, panic attacks.

There are some who are able to maintain normal levels of anxiety and see it as part of the ritual of a big life event. Unfortunately, others of us are rendered completely helpless from the condition and are the ones who are most likely to benefit from CBD as a natural supplement to control their anxiety. 

5 Key Findings for CBD as Natural Anxiety Relief

1. CBD is the most promising natural anxiety relief

There have been multiple scientific studies on the effects of CBD on anxiety. The basis from these showed that CBD is the most promising natural supplement with therapeutic benefits over anxiety.1 This is because those clinical studies confirmed that CBD has anxiolytic properties—the key ingredient to helping the brain naturally deal with anxiety. All of which was shown during a neuroimaging study to gauge levels of anxiety before and after speaking in public.2

One particular study showed that 600 mg of CBD given to patients will decrease levels of anxiety.3 Knowing that a 600 mg dosage is what enables people to reduce anxious thoughts allows producers of CBD products to create natural supplements for anxiety which work and are backed by science.

2. CBD is an increasingly popular alternative to pharmaceuticals

As there are no over-the-counter pharmaceutical medicines available to sufferers, natural remedies for anxiety and depression are becoming more widely used.

The number of Americans seeking complementary and alternative medicine in 2017 stood at 38%, with a further study showing that these levels remained largely the same. Global accounting powerhouse PwC predicts that medical costs will increase from 5.5% to 7% as more and more individuals seek safe, cost-effective herbal alternatives for anxiety.

CBD was tested alongside placebo medicine to see if it could be used as a herbal remedy for anxiety and replace pharmaceuticals. Both tests were conclusive in showing that CBD reduced feelings of anxiety versus the placebo drugs.3,4 With evidence showing CBD to be natural anxiety medication and with it being more widely available to buy, CBD will only increase in popularity.

3. CBD can significantly reduce Generalized Social Anxiety

Generalized Social Anxiety Disorder (SAD) is one of the most prevalent anxiety conditions across the globe. It’s commonly diagnosed through failing to adjust to everyday life and an overall lack of productivity and sense of worth. Many argue that it’s down to the greater integration of technology in our lives, but either way, SAD currently affects 6.8 million adults in the US and only 43.2% are receiving treatment.

With close to 60% going untreated, CBD which is readily available and in a form which can be easily taken can become a lifeline to so many. Oral CBD is shown in studies to be the most effective, seeing a peak after 1-2 hours of ingesting.5 So, those looking for supplements for anxiety should take CBD orally and at a dose of 600 mg6 to see SAD subside after 1-2 hours.

4. CBD is more than herbs for anxiety

Beyond anxiety, there is mounting evidence that CBD is an effective treatment for stress and post-traumatic stress disorder (PTSD). It’s argued that this is because a cannabinoid deficiency is prevalent in those who suffer from stress and PTSD.7 For those patients, being able to self-medicate with CBD can fill the gap in that deficiency and help to alleviate those symptoms. The effectiveness of CDB to treat PTSD was also cited in two further studies.1 They both found that CBD suppressed the fight or flight behaviors humans exhibit when faced with a predator. The same reactions largely associated with panic attacks and PTSD.8 Furthermore, very preliminary tests have shown that CBD can also reduce the effects of obsessive-compulsive disorder.9

5. A bright future for CBD anxiety treatment

Recent changes in legislation to Hemp in the 2018 Farm Bill means regulations on CBD are now less stringent. This will open up many more avenues to get CBD treatment to the consumers but also allow for a greater deal of clinical testing on its effectiveness.

Testing the prolonged success of CBD is recommend by a number of trials.10 A move which is welcomed by many, especially as it will help to clarify the powerful effects of taking CBD. At present, there are many companies claiming extraordinary cures from taking CBD. Focussing on what it can do best, be a natural remedy for anxiety and depression, CBD will help those who need it most.

References

 

  1. Alline Cristina Campos, Fabricio Araújo Moreira, Felipe Villela Gomes, Elaine Aparecida Del Bel, and Francisco Silveira Guimarães Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders367Philosophical Transactions of the Royal Society B: Biological Sciences
  2. Crippa J. A., et al. 2004 Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology 29, 417–426.d
  3. Bergamaschi M. M., et al. 2011 Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 36, 1219–1226.doi:10.1038/npp.2011.6
  4. Crippa, J.A.; Derenusson, G.N.; Ferrari, T.B.; Wichert-Ana, L.; Duran, F.L.; Martin-Santos, R.; Simões, M.V.; Bhattacharyya, S.; Fusar-Poli, P.; Atakan, Z.; et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report. J. Psychopharmacol. 2011, 25, 121–130.
  5. Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L. Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia. 1981;37:1090–1092.
  6. Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, et al. Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. Int J Neuropsychopharmacol. 2009a;13:421–432.
  7. N Hill, Matthew, et al. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder, Neuropsychopharmacology volume 43, pages 80–102 (2018)
  8. Campos A. C.& Guimarães F. S.. 2009Activation of 5HT1A receptors mediates the anxiolytic effects of cannabidiol in a PTSD model. Behav. Pharmacol. 20, S54.
  9. Casarotto P. C., Gomes F. V., Resstel L. B.& Guimarães F. S.. 2010Cannabidiol inhibitory effect on marble-burying behavior: involvement of CB1 receptors. Behav. Pharmacol. 21, 353–358
  10. Blessing, Esther M et al. “Cannabidiol as a Potential Treatment for Anxiety Disorders"Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics vol. 12,4 (2015): 825-36.


Leave a comment

Comments will be approved before showing up.